U.S. Markets close in 3 hrs 53 mins

Impax Laboratories, Inc. (IPXL)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.85+0.70 (+3.86%)
As of 12:06PM EDT. Market open.
People also watch
MDCOLCIENDPAKRXDEPO
Full screen
Previous Close18.15
Open18.20
Bid18.75 x 2100
Ask18.80 x 100
Day's Range18.00 - 18.90
52 Week Range7.75 - 31.85
Volume436,824
Avg. Volume1,756,633
Market Cap1.39B
Beta1.10
PE Ratio (TTM)-2.40
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press7 days ago

    Dominion Diamond and Impax rise; FedEx and BlackRock fall

    Stocks that moved substantially or traded heavily Monday: FedEx Corp., down $3.58 to $215.48 The logistics company said a cyberattack is still hurting its TNT Express business and will affect its full-year ...

  • TheStreet.com7 days ago

    Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta

    Impax Laboratories, Akebia Therapeutics and Alder BioPharmaceuticals were among the biotech movers in premarket trading on July 17.

  • Capital Cubelast month

    Impax Laboratories, Inc. – Value Analysis (NASDAQ:IPXL) : June 16, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Impax Laboratories, Inc. a score of 16. Our analysis is based on comparing Impax Laboratories, Inc. with the following peers – Mylan N.V., Lannett Company, Inc., Pfizer Inc., Shire PLC Sponsored ADR, Valeant Pharmaceuticals International Inc, Endo International Plc, Astrazeneca PLC Sponsored ADR and Teva Pharmaceutical Industries ... Read more (Read more...)